SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-18-000385
Filing Date
2018-02-13
Accepted
2018-02-13 08:21:49
Documents
1
Group Members
JAFCO CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A AMENDMENT 2 jafco_sc13ga2-123117.htm SC 13G/A 64490
  Complete submission text file 0001683168-18-000385.txt   66297
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88629 | Film No.: 18599201
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Filed by) CIK: 0001590442 (see all company filings)

IRS No.: 980581564 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13G/A